Overview
Observational Study to Observe the Efficacy of Levemir® (Insulin Detemir) in Patients With Type 2 Diabetes.
Status:
Completed
Completed
Trial end date:
2011-01-01
2011-01-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study is conducted in Europe. The aim of this observational study is to observe the efficacy of Levemir® treatment in patients with type 2 diabetes in everyday clinical practice in Switzerland. Furthermore the time period between diagnosis of type 2 diabetes and insulin initiation is evaluated.Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Novo Nordisk A/STreatments:
Insulin
Insulin Detemir
Insulin, Globin Zinc
Criteria
Inclusion Criteria:- Patients with type 2 diabetes mellitus
- Insulin-naive or currently treated with another basal insulin
- Inclusion of patients at the discretion of the treating physician after the decision
to prescribe Levemir®
Exclusion Criteria:
- Type 1 diabetes mellitus
- Patients treated with short acting or with premix insulin
- Women who are pregnant, breast feeding or have the intention to become pregnant
- Known or suspected allergy to the study product or related product
- Any exclusion criteria according to the Swiss Levemir® SPC (Summary of Product
Characteristics)